Alkaline ophthalmic suspensions

Details Alkaline ophthalmic suspensions Alkaline ophthalmic suspensions

1993-02-08

1994-08-23

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Topical body preparation containing solid synthetic organic...

Ophthalmic preparation

424427, 424428, 424489, 514912, 514913, 514914, A61K 3174, A61K 914, A61F 214

Patent

active

053405722

ABSTRACT:
Topical ophthalmic medicament delivery system combining an aqueous ophthalmic gel suspension at a pH equal to or greater than 7.5 and an osmotic pressure of from 10 to about 400 mOsM containing a pharmaceutically effective amount of one or more ophthalmic medicaments of from about 0.05% to about 10% by weight, based on the total weight of the suspension, of a carboxyl-containing polymer prepared by polymerizing one or more carboxyl-containing monoethylenically unsaturated monomers and less then about 5% by weight of a cross-linking agent. The systems have a viscosity of from about 1,000 to about 30,000 centiposes prior to administration to the eye and remain a gel in the eye for a prolonged period of time allowing for the sustained release of one or medicaments such as amine containing antibiotics alone or in combination with cortiscosteroids.

REFERENCES:
patent: 2798053 (1957-07-01), Brown
patent: 3947573 (1976-03-01), Rankin
patent: 4039662 (1977-08-01), Hecht et al.
patent: 4127674 (1978-11-01), Leopold
patent: 4136250 (1979-01-01), Mueller et al.
patent: 4192827 (1980-03-01), Mueller et al.
patent: 4230724 (1980-10-01), Cooper et al.
patent: 4271143 (1981-06-01), Schoenwald et al.
patent: 4407791 (1983-04-01), Stark
patent: 4407792 (1983-10-01), Schoenwald et al.
patent: 4443432 (1984-04-01), Garabedian et al.
patent: 4461904 (1984-07-01), York
patent: 4474751 (1984-10-01), Haslam et al.
patent: 4478818 (1984-10-01), Shell et al.
patent: 4524063 (1985-06-01), Wheeler
patent: 4548990 (1985-10-01), Mueller et al.
patent: 4559343 (1985-12-01), Han et al.
patent: 4615697 (1986-10-01), Robinson
patent: 4617186 (1986-10-01), Schafer et al.
patent: 4644007 (1987-02-01), York
patent: 4686214 (1987-08-01), Boltralik
patent: 4717725 (1988-03-01), York, Jr.
patent: 4737492 (1988-04-01), Gerson et al.
patent: 4820737 (1989-04-01), Schoenwald et al.
patent: 4822819 (1989-04-01), Desantis et al.
patent: 4888168 (1989-12-01), Potts et al.
patent: 4911920 (1990-03-01), Jani et al.
patent: 5106615 (1992-04-01), Dikstein
Pharmaceutica Acta Helvetiae, vol. 39, pp. 615 et seq.
Pharmaceutica Acta Helvetiae, vol. 39, pp. 546 et seq (1964).
Canadian Journal of Pharmaceutical Sciences 10, No. 1, 1975, pp. 16-20.
Ophthalmology, vol. 91, No. 1, Oct. 1984, pp. 1199-1204.
Klin. Mbl. Augenheilk. 189 (1986), pp. 51-54 pp. 254-256.

Affiliated with

Also associated with

Rating

Alkaline ophthalmic suspensions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkaline ophthalmic suspensions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkaline ophthalmic suspensions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-501206